Stroke patients evaluated using telemedicine (telestroke) have higher odds of receiving essential treatment, yet it takes them significantly longer to be treated-potentially limiting the benefits, a Michigan Medicine-led study finds.

Researchers evaluated more than 3,000 patients with ischemic stroke, the most common type, who were potentially eligible for treatment with thrombolysis.

The study used data from 42 hospitals in the Paul Coverdell Michigan Stroke Registry, a program funded by the Centers for Disease Control and Prevention that measures, tracks and aims to improve the quality of care for patients with stroke.

Also called clot-busting medication, thrombolysis is highly time sensitive. National stroke guidelines from the American Heart Association recommend thrombolysis treat

See Full Page